These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Management of HIV infection in Nigeria with zalcitabine in combination with saquinavir mesylate: preliminary findings. Akinsete I; Njoku OS; Okanny CC; Chukwuani CM; Akanmu AS; West Afr J Med; 2000; 19(4):265-8. PubMed ID: 11391837 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors. Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Kiertiburanakul S; Anekthananon T; Bowonwatanuwong C; Kowadisaiburana B; Supparatpinyo K; Ruxrungtham K; HIV Med; 2007 Nov; 8(8):529-35. PubMed ID: 17944686 [TBL] [Abstract][Full Text] [Related]
27. NDA submitted for new formulation of saquinavir. AIDS Patient Care STDS; 1997 Aug; 11(4):288-9. PubMed ID: 11361847 [No Abstract] [Full Text] [Related]
28. Saquinavir: newest weapon in the antiviral arsenal. MacDougall DS J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):25-31. PubMed ID: 11363336 [TBL] [Abstract][Full Text] [Related]
29. Sex differences in adverse reactions to antiretroviral drugs. Ofotokun I; Pomeroy C Top HIV Med; 2003; 11(2):55-9. PubMed ID: 12717043 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy. Lopez-Cortes LF; Ruiz-Valderas R; Rivero A; Camacho A; Marquez-Solero M; Santos J; García-Lazaro M; Viciana P; Rodriguez-Baños J; Ocampo A Ther Drug Monit; 2007 Apr; 29(2):171-6. PubMed ID: 17417070 [TBL] [Abstract][Full Text] [Related]
31. Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study). Lamotte C; Landman R; Peytavin G; Mentre F; Gerbe J; Brun-Vezinet F; Boue F; Spiridon G; Valantin MA; Michelet C; Farinotti R; Yeni P Antivir Ther; 2004 Apr; 9(2):247-56. PubMed ID: 15134187 [TBL] [Abstract][Full Text] [Related]
33. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7. Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744 [TBL] [Abstract][Full Text] [Related]
35. A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors. Kirk O; Lundgren JD; Pedersen C; Mathiesen LR; Nielsen H; Katzenstein TL; Obel N; Gerstoft J Antivir Ther; 2003 Dec; 8(6):595-602. PubMed ID: 14760893 [TBL] [Abstract][Full Text] [Related]
36. New saquinavir formula more potent than original. Bartnof HS BETA; 1997 Sep; ():45. PubMed ID: 11364701 [TBL] [Abstract][Full Text] [Related]
37. Why the old saquinavir (Invirase) may be bad for your health. Vazquez E Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485 [TBL] [Abstract][Full Text] [Related]
38. Upcoming compassionate use programs for two new antiretrovirals will begin this fall. Schouten J STEP Perspect; 1999; 99(3):16. PubMed ID: 11366864 [TBL] [Abstract][Full Text] [Related]
39. A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. Ananworanich J; Hill A; Siangphoe U; Ruxrungtham K; Prasithsirikul W; Chetchotisakd P; Kiertiburanakul S; Munsakul W; Raksakulkarn P; Tansuphasawadikul S; Nuesch R; Cooper DA; Hirschel B; Antivir Ther; 2005; 10(6):761-7. PubMed ID: 16218176 [TBL] [Abstract][Full Text] [Related]
40. Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults. Ribera E; Lopez RM; Diaz M; Pou L; Ruiz L; Falcó V; Crespo M; Azuaje C; Ruiz I; Ocaña I; Clotet B; Pahissa A Antimicrob Agents Chemother; 2004 Nov; 48(11):4256-62. PubMed ID: 15504850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]